U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1175T>C (p.Val392Ala) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 24, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003235010.1

Allele description [Variation Report for NM_000492.4(CFTR):c.1175T>C (p.Val392Ala)]

NM_000492.4(CFTR):c.1175T>C (p.Val392Ala)

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1175T>C (p.Val392Ala)
HGVS:
  • NC_000007.14:g.117542074T>C
  • NG_016465.4:g.81291T>C
  • NM_000492.4:c.1175T>CMANE SELECT
  • NP_000483.3:p.Val392Ala
  • NP_000483.3:p.Val392Ala
  • LRG_663t1:c.1175T>C
  • LRG_663:g.81291T>C
  • LRG_663p1:p.Val392Ala
  • NC_000007.13:g.117182128T>C
  • NM_000492.3:c.1175T>C
Protein change:
V392A
Links:
dbSNP: rs397508170
NCBI 1000 Genomes Browser:
rs397508170
Molecular consequence:
  • NM_000492.4:c.1175T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003934579Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(May 24, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?

Dorfman R, Nalpathamkalam T, Taylor C, Gonska T, Keenan K, Yuan XW, Corey M, Tsui LC, Zielenski J, Durie P.

Clin Genet. 2010 May;77(5):464-73. doi: 10.1111/j.1399-0004.2009.01351.x. Epub 2009 Jan 6.

PubMed [citation]
PMID:
20059485

A combined analysis of the cystic fibrosis transmembrane conductance regulator: implications for structure and disease models.

Chen JM, Cutler C, Jacques C, Boeuf G, Denamur E, Lecointre G, Mercier B, Cramb G, FĂ©rec C.

Mol Biol Evol. 2001 Sep;18(9):1771-88.

PubMed [citation]
PMID:
11504857
See all PubMed Citations (3)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003934579.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: CFTR c.1175T>C (p.Val392Ala) results in a non-conservative amino acid change located in the ATP-binding cassette domain (IPR047082) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 250960 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1175T>C has been reported in the literature in at least one compound heterozygous individual affected with Congenital Bilateral Absence Of The Vas Deferens, in trans with the F508del variant (e.g., Chen_2001, Dorfman_2010, SickKids Cystic Fibrosis Mutation Database). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 11504857, 20059485, 35913788). One ClinVar submitter (evaluation after 2014) has cited the variant and classified it as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 19, 2024